Skip to main content

Bluejay Diagnostics, Inc. (BJDX)

NASDAQ: BJDX · IEX Real-Time Price · USD
2.33
-0.24 (-9.34%)
At close: Dec 3, 2021 4:00 PM
2.38
0.05 (2.15%)
After-hours:Dec 3, 2021 7:58 PM EST
Market Cap29.45M
Revenue (ttm)n/a
Net Income (ttm)-1.51M
Shares Out12.64M
EPS (ttm)-0.12
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,011,443
Open2.58
Previous Close2.57
Day's Range2.28 - 2.63
52-Week Range2.28 - 6.25
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About BJDX

Bluejay Diagnostics is a late-stage pre-revenue company focused on improving patient outcomes through a more cost efficient, rapid, near patient product for triage, diagnosis and monitoring of disease progression. Our diagnostic system, which we refer to as “Symphony,” is an exclusively licensed, patented, low-cost, system that consists of a small footprint instrument and single-use indication specific test cartridges, that can provide laboratory quality results in approximately 24 minutes, in the clinic, ICU, ER and in other hospital and c...

IndustryMedical Devices
IPO DateNov 10, 2021
CEONeil Dey
Employees5
Stock ExchangeNASDAQ
Ticker SymbolBJDX
Full Company Profile

Financial Performance

Financial Statements

News

Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering

ACTON, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”) a late-stage, pre-revenue diagnostics/medical device company focused on developing cost-effective, ra...

3 weeks ago - GlobeNewsWire

Bluejay Diagnostics IPO Registration Document (S-1)

Bluejay Diagnostics, Inc. has filed to go public with an IPO on the NASDAQ.

1 month ago - SEC